Headquartered in Stuart, Florida, Stuart Therapeutics, Inc. is a clinical-stage drug platform company addressing DED, Glaucoma, Myopia and Retinal Diseases, such as Diabetic Retinopathy. The company is the leader in the research and development of therapeutics targeting the ocular extracellular matrix.
Company Details
- Employees
- 11
- Address
- Stuart, Fl
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://stuarttherapeutics.com
- HQ
- Stuart, FL
Stuart Therapeutics Questions
Stuart Therapeutics's website is http://stuarttherapeutics.com
Stuart Therapeutics's LinkedIn profile is https://www.linkedin.com/company/stuart-therapeutics
Stuart Therapeutics has
11 employees.
View email and phone details for 11
employees at Stuart Therapeutics.
Stuart Therapeutics's industry is
Biotechnology Research
Stuart Therapeutics's top competitors are
Enveric Biosciences, Inc.,
Immunic Therapeutics,
Annexin Pharmaceuticals Ab (Publ),
Tarsier Pharma,
Monument Therapeutics,
Arialys Therapeutics,
Mediprint Ophthalmics,
Hilco Vision,
Neurizon,
Ventyx Biosciences.
Stuart Therapeutics's categories are Biotechnology Research
